
Buda Juice fell 26.1% from $8.11 to $5.99, behind the S&P 500's +6.2%. Its worst day was Nov 13 (−12.3%), and its low came Nov 13 at $5.99.
Jan 8, 2026 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Buda Juice shares rose 14.6%, while the S&P 500 fell 0.3%.
+14.6%, the year's best day · S&P 500 −0.3%
Buda Juice shares rose 11.9%, while the S&P 500 fell 0.6%.
+11.9% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
EPS of $0.20 was reported on $12.6M revenue.
0.0% · S&P 500 −1.8%
EPS of $0.05 beat the $0.03 estimate on $3.5M revenue (est. $3.2M).
−3.4% · S&P 500 +0.6%
Buda Juice shares rose 12.6%, while the S&P 500 rose 0.5%.
+12.6% · S&P 500 +0.5%
Buda Juice shares rose 13.0%, while the S&P 500 fell 0.7%.
+13.0% · S&P 500 −0.7%
Buda Juice closed at its highest level of the year, 33.9% above where the year started.
+6.7% · S&P 500 +0.4%
EPS of $0.04 missed the $0.05 estimate on $4.5M revenue (est. $3.8M).
−10.5% · S&P 500 +0.7%
EPS of $0.07 beat the $0.03 estimate on $5.2M revenue (est. $4.5M).
−12.3%, the year's worst day · S&P 500 −0.4%
Where it ended: a close of $5.99 on Nov 17, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $0.03, revenue est. $4.3M).
Nothing in the past 12 months.
All BUDA dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BUDA and SPY from Benzinga historical bars. Not investment advice.